Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Indian-origin chemist jailed for illegal sale of drugs in UK

      Indian-origin chemist jailed for illegal sale of drugs in UK

      Ruby Khatun Khatun19 Jun 2017 9:34 AM IST
      LONDON: An Indian-origin pharmacist who stole almost 5,000 pounds worth of prescription drugs and then sold them on the street has been jailed for one...
      TUV Rheinland India enter partnership with Andhra Pradesh MedTec Zone to deliver medical devices

      TUV Rheinland India enter partnership with Andhra Pradesh MedTec Zone to deliver medical devices

      Ruby Khatun Khatun19 Jun 2017 9:26 AM IST
      Hyderabad: TUV Rheinland India, a subsidiary of TUV Rheinland Group, Germany, a worldwide leader in Testing, Training, Inspection, Consulting and...
      Google bets on European biotech drugs, backs new fund

      Google bets on European biotech drugs, backs new fund

      Ruby Khatun Khatun19 Jun 2017 9:26 AM IST
      LONDON: Google is betting on the potential of European biotech companies to deliver life-changing drugs by investing alongside Swiss company Novartis...
      New test may turn AstraZenecas Lynparza into precision drug for prostate cancer

      New test may turn AstraZeneca's Lynparza into precision drug for prostate cancer

      Ruby Khatun Khatun19 Jun 2017 9:26 AM IST
      LONDON: Scientists have developed a new three-in-one blood test that has the potential to turn AstraZeneca's drug Lynparza into a precision medicine...
      Sanofi to invest further in biologics production

      Sanofi to invest further in biologics production

      Ruby Khatun Khatun18 Jun 2017 11:28 AM IST
      Paris: Sanofi announced plans to invest 600 million euros ($673 million) annually over the next two to three years in the field of biologics...
      Lupin launches antidepressant tablets in US

      Lupin launches antidepressant tablets in US

      Ruby Khatun Khatun18 Jun 2017 11:28 AM IST
      New Delhi: Drug firm Lupin has launched its antidepressant Bupropion Hydrochloride extended release tablets used for treatment of major depressive...
      Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab

      Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab

      Ruby Khatun Khatun18 Jun 2017 11:25 AM IST
      New York & Indianapolis: Pfizer Inc. and Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track...
      Government of India bans Ofloxacin, Ornidazole injection combination

      Government of India bans Ofloxacin, Ornidazole injection combination

      Ruby Khatun Khatun18 Jun 2017 11:22 AM IST
      Department of Health and Family Welfare of Ministry of Health and Family Welfare, Government of India has banned fixed dose combinations of Ofloxacin...
      Portea Medical expands digital health initiatives for physiotherapy with Physitrack

      Portea Medical expands digital health initiatives for physiotherapy with Physitrack

      Ruby Khatun Khatun18 Jun 2017 9:35 AM IST
      Bangalore: Portea Medical, India's leading home healthcare provider, has expanded its digital health initiatives with the launch of a project in...
      Quadria founders-led Healthquad closes debut fund

      Quadria founders-led Healthquad closes debut fund

      Ruby Khatun Khatun18 Jun 2017 9:06 AM IST
      New Delhi: India's leading specialist healthcare focused venture capital fund 'Healthquad' has achieved its final close with a total commitment of...
      OptiMaser signs an MOU with IITR to synergize Microwave technology for Infection Control

      OptiMaser signs an MOU with IITR to synergize Microwave technology for Infection Control

      Ruby Khatun Khatun17 Jun 2017 11:31 AM IST
      Lucknow: In another big step towards realizing a massive movement of the hon’ble Prime Minister Shri Narendra Modi that seeks to create a Clean India...
      Aurobindo Pharma gets USFDA nod for oral suspension

      Aurobindo Pharma gets USFDA nod for oral suspension

      Ruby Khatun Khatun17 Jun 2017 11:29 AM IST
      New Delhi: Drug firm Aurobindo Pharma has received USFDA nod to make oral suspension used for controlling serum phosphorus in patients with chronic...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok